SunOpta reports Q3 adjusted EPS 5c, consensus 3c

Reports Q3 revenue $205.4M, consensus $195.57M. “We delivered outstanding revenue growth in the third quarter and affirmed the strength of our competitive position, the diversity of our revenue streams and the robust demand across our portfolio,” said CEO Brian Kocher. “During the quarter, the combination of category tailwinds and several pipeline opportunities, that were originally anticipated for 2026, accelerated our revenue growth resulting in a 17% volume increase. While the speed and magnitude of the volume growth stressed our supply chain, I’m proud of the team for exceeding our production targets to support this growth and confident in our ability to return to planned gross margin expansion activities by mid-2026. Our new business pipeline and category demand are exceeding expectations. Customers are demanding additional capacity at a rate and speed we had not anticipated. Accordingly, we are announcing a new aseptic manufacturing line at our Midlothian, Texas facility that is already over 50% subscribed and will come online in late 2026. Along with the previously announced fruit snack line in Omak, Washington, we are positioned to meet expected market demand through the end of 2028.”